Sarfati, S.; Wils, J.; Lambert, T.; Mory, C.; Imbert, L.; Gargala, G.; Morisse-Pradier, H.; Lamoureux, F.
Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis. Pharmaceutics 2022, 14, 1598.
https://doi.org/10.3390/pharmaceutics14081598
AMA Style
Sarfati S, Wils J, Lambert T, Mory C, Imbert L, Gargala G, Morisse-Pradier H, Lamoureux F.
Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis. Pharmaceutics. 2022; 14(8):1598.
https://doi.org/10.3390/pharmaceutics14081598
Chicago/Turabian Style
Sarfati, Sacha, Julien Wils, Timothée Lambert, Céline Mory, Laurent Imbert, Gilles Gargala, Hélène Morisse-Pradier, and Fabien Lamoureux.
2022. "Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis" Pharmaceutics 14, no. 8: 1598.
https://doi.org/10.3390/pharmaceutics14081598
APA Style
Sarfati, S., Wils, J., Lambert, T., Mory, C., Imbert, L., Gargala, G., Morisse-Pradier, H., & Lamoureux, F.
(2022). Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis. Pharmaceutics, 14(8), 1598.
https://doi.org/10.3390/pharmaceutics14081598